[go: up one dir, main page]

Sun et al., 2022 - Google Patents

Multi-stimuli-responsive janus hollow polydopamine nanotubes

Sun et al., 2022

Document ID
9357575221391458126
Author
Sun Y
Davis E
Publication year
Publication venue
Langmuir

External Links

Snippet

A tubular-shaped Janus nanoparticle based on polydopamine that responds to near- infrared, magnetic, and pH stimuli is reported. The robust tubular polydopamine structure was obtained by optimizing the halloysite template-to-dopamine ratio during synthesis. The …
Continue reading at pubs.acs.org (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
    • A61K9/5153—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
    • A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
    • A61K47/48769—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form
    • A61K47/48853—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form the form being a particulate, powder, adsorbate, bead, sphere
    • A61K47/48861—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form the form being a particulate, powder, adsorbate, bead, sphere the form being an inorganic particle, e.g. a ceramic particle, silica particle, ferrite, synsorb
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5192—Processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0009—Galenical forms characterised by the drug release technique; Application systems commanded by energy involving or responsive to electricity, magnetism or acoustic waves; Galenical aspects of sonophoresis, iontophoresis, electroporation or electroosmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application

Similar Documents

Publication Publication Date Title
Seaberg et al. Hybrid nanosystems for biomedical applications
Le et al. Janus particles: recent advances in the biomedical applications
Sánchez-Moreno et al. Thermo-sensitive nanomaterials: recent advance in synthesis and biomedical applications
Chen et al. Spatial, temporal, and dose control of drug delivery using noninvasive magnetic stimulation
Karimi et al. Temperature-responsive smart nanocarriers for delivery of therapeutic agents: applications and recent advances
Zhang et al. Polymer-coated hollow mesoporous silica nanoparticles for triple-responsive drug delivery
Xia et al. Polyethyleneimine coating enhances the cellular uptake of mesoporous silica nanoparticles and allows safe delivery of siRNA and DNA constructs
Lee et al. Photothermally controllable cytosolic drug delivery based on core–shell MoS2-porous silica nanoplates
Zheng et al. Polydopamine-coated magnetic composite particles with an enhanced photothermal effect
Zhang et al. Multifunctional envelope-type mesoporous silica nanoparticles for tumor-triggered targeting drug delivery
Zhang et al. Janus nanoparticles in cancer diagnosis, therapy and theranostics
Vazquez-Gonzalez et al. Aptamer-functionalized micro-and nanocarriers for controlled release
Liu et al. Design of hybrid nanovehicles for remotely triggered drug release: an overview
Kobayashi et al. Surface engineering of nanoparticles for therapeutic applications
Hai et al. DNA-functionalized hollow mesoporous silica nanoparticles with dual cargo loading for near-infrared-responsive synergistic chemo-photothermal treatment of cancer cells
Poostforooshan et al. Aerosol-assisted synthesis of tailor-made hollow mesoporous silica microspheres for controlled release of antibacterial and anticancer agents
Dai et al. Dendrimerlike mesoporous silica nanoparticles as pH-responsive nanocontainers for targeted drug delivery and bioimaging
Wang et al. Near-infrared-light-responsive magnetic DNA microgels for photon-and magneto-manipulated cancer therapy
Sharma et al. Multilayer capsules made of weak polyelectrolytes: A review on the preparation, functionalization and applications in drug delivery
Zhang et al. Porous silicon nanomaterials: recent advances in surface engineering for controlled drug-delivery applications
Huang et al. Plasmonic gold nanovesicles for biomedical applications
Zhao et al. pH-sensitive fluorescent hepatocyte-targeting multilayer polyelectrolyte hollow microspheres as a smart drug delivery system
Li et al. Sonochemical synthesis of hydrophilic drug loaded multifunctional bovine serum albumin nanocapsules
Luo et al. Recent progress in macromolecule‐anchored hybrid gold nanomaterials for biomedical applications
Zhao et al. Preparation of aggregation-resistant biocompatible superparamagnetic noncovalent hybrid multilayer hollow microspheres for controlled drug release